- Home
- PIII vs NTIP Comparison
PIII vs NTIP Comparison
Compare PIII & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIII
- NTIP
- Stock Information
- Founded
- PIII 2015
- NTIP 1990
- Country
- PIII United States
- NTIP United States
- Employees
- PIII N/A
- NTIP N/A
- Industry
- PIII Medical/Nursing Services
- NTIP Multi-Sector Companies
- Sector
- PIII Health Care
- NTIP Miscellaneous
- Exchange
- PIII Nasdaq
- NTIP Nasdaq
- Market Cap
- PIII 21.4M
- NTIP 28.6M
- IPO Year
- PIII N/A
- NTIP 1998
- Fundamental
- Price
- PIII $6.23
- NTIP $1.34
- Analyst Decision
- PIII Buy
- NTIP
- Analyst Count
- PIII 2
- NTIP 0
- Target Price
- PIII $16.25
- NTIP N/A
- AVG Volume (30 Days)
- PIII 3.7K
- NTIP 23.9K
- Earning Date
- PIII 08-06-2025
- NTIP 08-11-2025
- Dividend Yield
- PIII N/A
- NTIP 7.46%
- EPS Growth
- PIII N/A
- NTIP N/A
- EPS
- PIII N/A
- NTIP N/A
- Revenue
- PIII $1,485,192,000.00
- NTIP $250,000.00
- Revenue This Year
- PIII N/A
- NTIP N/A
- Revenue Next Year
- PIII $6.01
- NTIP N/A
- P/E Ratio
- PIII N/A
- NTIP N/A
- Revenue Growth
- PIII 9.79
- NTIP N/A
- 52 Week Low
- PIII $6.00
- NTIP $1.16
- 52 Week High
- PIII $32.54
- NTIP $1.78
- Technical
- Relative Strength Index (RSI)
- PIII 42.33
- NTIP 62.14
- Support Level
- PIII $6.00
- NTIP $1.20
- Resistance Level
- PIII $6.46
- NTIP $1.30
- Average True Range (ATR)
- PIII 0.21
- NTIP 0.06
- MACD
- PIII 0.07
- NTIP 0.01
- Stochastic Oscillator
- PIII 33.33
- NTIP 69.23
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.